Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd‐Chiari Syndrome without myeloproliferative neoplasm
- 21 September 2016
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 180 (3) , 443-445
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rateHaematologica, 2014
- SomaticCALRMutations in Myeloproliferative Neoplasms with NonmutatedJAK2New England Journal of Medicine, 2013
- Blood and endothelial cells: together through thick and thinBlood, 2013
- Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysisBlood, 2012
- Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasmsBlood, 2011
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndromeBlood, 2009
- Flow cytometric evaluation of circulating endothelial cells: A new protocol for identifying endothelial cells at several stages of differentiationAmerican Journal of Hematology, 2007
- JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorderLeukemia, 2007